PUBLISHER: IMARC | PRODUCT CODE: 1541057
PUBLISHER: IMARC | PRODUCT CODE: 1541057
The global medical exoskeleton market size reached US$ 378.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 4,508.6 Million by 2032, exhibiting a growth rate (CAGR) of 30.73% during 2024-2032.
A medical exoskeleton is an electromechanical device that supports the human musculoskeletal system for rehabilitation and enables an injured or paraplegic person to stand and walk. It relies on a combination of springs and dampers that can store energy from human motion and reuse it when required to enhance a posture or motion. It also uses actuators that convert electrical, air, or hydraulic energy into mechanical force to support and strengthen the human movement. It is employed in the military sector to give soldiers additional protection and abilities during warfare. It is also used in the construction sector to reduce fatigue and back, neck, and shoulder pain.
At present, the growing incidences of spinal cord injuries (SCI) due to falls, road traffic crashes, or violence represent one of the key factors driving the market. Besides this, there is a rise in the demand for medical exoskeletons in various industries to support employee health and boost productivity around the world. This, along with the rising number of startups that expertise in exoskeleton technology and provide solutions for rehabilitation, is positively influencing the market. Moreover, key market players are financing research and development (R&D) activities to introduce anti-radiation aprons for health workers suffering from neck and back problems. They are also focusing on launching a robotic partial knee orthosis used by wearers to reduce knee pain and regain mobility. In addition, the growing prevalence of musculoskeletal injuries and disorders, such as occupational overuse syndrome (OOS), cumulative trauma disorders (CTD), and repetitive strain injury (RSI), is offering a positive market outlook.
IMARC Group provides an analysis of the key trends in each sub-segment of the global medical exoskeleton market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on component, type, extremity, mobility and end user.
Hardware
Software
Powered Exoskeletons
Passive Exoskeletons
Lower Extremity Medical Exoskeletons
Upper Extremity Medical Exoskeletons
Full Body
Mobile Exoskeletons
Stationary Exoskeletons
Rehabilitation Centers
Physiotherapy Centers
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being B-Temia Inc., Cyberdyne Inc., Ekso Bionics Holdings Inc., ExoAtlet Global S.A., GOGOA Mobility Robots, Hocoma AG (DIH International Limited), Myomo Inc., ReWalk Robotics Ltd, Rex Bionics Ltd., suitX Inc. (Ottobock SE & Co. KGaA), Wandercraft and Wearable Robotics Srl.